Ligand validation:2VDK

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2VDK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VDK_NAG_B_3099	2%	64%	0.411	0.706	0.54	0.83	-	-	0	0	100%	0.9333
2VDK_NAG_A_3249	1%	60%	0.504	0.719	0.6	0.92	-	1	0	0	100%	0.6533
2VDK_NAG_A_3015	1%	56%	0.504	0.681	0.59	1.09	-	2	0	0	100%	0.9333
7THO_NAG_B_2004	35%	49%	0.094	0.781	1.08	0.88	2	-	0	0	100%	0.9333
7UDG_NAG_D_2003	34%	70%	0.098	0.777	0.42	0.71	-	1	0	0	100%	0.9333
7UJE_NAG_B_2004	33%	77%	0.115	0.792	0.39	0.52	-	-	0	0	100%	0.9333
7TCT_NAG_B_2004	31%	75%	0.129	0.797	0.42	0.54	-	-	0	0	100%	0.9333
7UK9_NAG_B_2004	31%	78%	0.115	0.78	0.3	0.59	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.